Enhabit Return on Investment 2020-2024 | EHAB
Current and historical return on investment (ROI) values for Enhabit (EHAB) over the last 10 years.
| Enhabit ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2024-09-30 | $-0.07B | $1.10B | -5.79% |
| 2024-06-30 | $0.04B | $1.21B | 3.02% |
| 2024-03-31 | $-0.05B | $1.23B | -3.97% |
| 2023-12-31 | $-0.05B | $1.23B | -3.82% |
| 2023-09-30 | $-0.15B | $1.24B | -11.30% |
| 2023-06-30 | $-0.14B | $1.24B | -10.19% |
| 2023-03-31 | $-0.03B | $1.32B | -2.42% |
| 2022-12-31 | $-0.01B | $1.33B | -0.85% |
| 2022-09-30 | $0.12B | $1.41B | 8.01% |
| 2022-06-30 | $0.13B | $1.40B | 11.59% |
| 2022-03-31 | $0.14B | $1.50B | 18.92% |
| 2021-12-31 | $0.14B | $1.48B | 38.60% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.385B | $1.046B |
| Enhabit Inc. provides home health and hospice services. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration and skilled observation and assessment services; practices to treat chronic diseases and conditions. Enhabit Inc., formerly known as EHABIT INC, is based in Dallas, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $84.874B | 10.53 |
| Cencora (COR) | United States | $44.008B | 16.55 |
| DiDi Global (DIDIY) | China | $22.650B | 0.00 |
| Natera (NTRA) | United States | $21.372B | 0.00 |
| ICON (ICLR) | Ireland | $17.119B | 15.25 |
| Viatris (VTRS) | United States | $14.944B | 4.60 |
| Avantor (AVTR) | United States | $14.436B | 21.64 |
| Revvity (RVTY) | United States | $13.699B | 23.80 |
| BioMerieux (BMXMF) | France | $12.615B | 0.00 |
| CochLear (CHEOY) | Australia | $11.851B | 0.00 |
| Solventum (SOLV) | United States | $11.545B | 0.00 |
| Doximity (DOCS) | United States | $10.796B | 63.55 |
| Medpace Holdings (MEDP) | United States | $10.483B | 29.53 |
| Charles River Laboratories (CRL) | United States | $9.500B | 18.36 |
| HealthEquity (HQY) | United States | $8.229B | 41.28 |
| Sonic Healthcare (SKHHY) | Australia | $8.181B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.339B | 29.51 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Organon (OGN) | United States | $3.755B | 3.79 |
| Sotera Health (SHC) | United States | $3.750B | 20.06 |
| BrightSpring Health Services (BTSG) | United States | $3.007B | 63.96 |
| Surgery Partners (SGRY) | United States | $2.697B | 30.75 |
| Concentras Parent (CON) | United States | $2.551B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.285B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.126B | 0.00 |
| Premier (PINC) | United States | $2.091B | 10.88 |
| Alignment Healthcare (ALHC) | United States | $2.034B | 0.00 |
| PACS (PACS) | United States | $1.983B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.692B | 44.40 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.651B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.625B | 0.00 |
| Progyny (PGNY) | United States | $1.221B | 24.72 |
| Pediatrix Medical (MD) | United States | $1.210B | 11.84 |
| Embecta (EMBC) | United States | $1.176B | 8.22 |
| Establishment Labs Holdings (ESTA) | $1.120B | 0.00 | |
| CareDx (CDNA) | United States | $1.105B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.873B | 5.91 |
| Agilon Health (AGL) | United States | $0.812B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| SBC Medicals (SBC) | United States | $0.622B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.568B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.501B | 0.00 |
| DocGo (DCGO) | United States | $0.460B | 17.35 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.297B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.272B | 0.00 |
| Biodesix (BDSX) | United States | $0.228B | 0.00 |
| LifeMD (LFMD) | United States | $0.218B | 0.00 |
| Beauty Health (SKIN) | United States | $0.181B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| ModivCare (MODV) | United States | $0.159B | 8.63 |
| MultiPlan (MPLN) | United States | $0.097B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.092B | 0.00 |
| So-Young (SY) | China | $0.091B | 15.40 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeueHealth (NEUE) | United States | $0.032B | 0.84 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |